These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 2208148)
1. ras gene mutations in human prostate cancer. Carter BS; Epstein JI; Isaacs WB Cancer Res; 1990 Nov; 50(21):6830-2. PubMed ID: 2208148 [TBL] [Abstract][Full Text] [Related]
2. Activated ras alleles in human carcinoma of the prostate are rare. Gumerlock PH; Poonamallee UR; Meyers FJ; deVere White RW Cancer Res; 1991 Mar; 51(6):1632-7. PubMed ID: 1998954 [TBL] [Abstract][Full Text] [Related]
3. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584 [TBL] [Abstract][Full Text] [Related]
4. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas. Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192 [TBL] [Abstract][Full Text] [Related]
5. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers. Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571 [TBL] [Abstract][Full Text] [Related]
6. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride. Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162 [TBL] [Abstract][Full Text] [Related]
7. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014 [TBL] [Abstract][Full Text] [Related]
9. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer. Rochlitz CF; Scott GK; Dodson JM; Liu E; Dollbaum C; Smith HS; Benz CC Cancer Res; 1989 Jan; 49(2):357-60. PubMed ID: 2642738 [TBL] [Abstract][Full Text] [Related]
10. Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations. Shiraishi T; Muneyuki T; Fukutome K; Ito H; Kotake T; Watanabe M; Yatani R Anticancer Res; 1998; 18(4B):2789-92. PubMed ID: 9713462 [TBL] [Abstract][Full Text] [Related]
11. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Anwar K; Nakakuki K; Shiraishi T; Naiki H; Yatani R; Inuzuka M Cancer Res; 1992 Nov; 52(21):5991-6. PubMed ID: 1382850 [TBL] [Abstract][Full Text] [Related]
12. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
13. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Sugio K; Ishida T; Yokoyama H; Inoue T; Sugimachi K; Sasazuki T Cancer Res; 1992 May; 52(10):2903-6. PubMed ID: 1581907 [TBL] [Abstract][Full Text] [Related]
14. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
15. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer. Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039 [TBL] [Abstract][Full Text] [Related]
16. H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes. Yoo J; Robinson RA; Lee JY Mod Pathol; 1999 Aug; 12(8):775-80. PubMed ID: 10463479 [TBL] [Abstract][Full Text] [Related]
17. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. Kumar R; Angelini S; Hemminki K Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681 [TBL] [Abstract][Full Text] [Related]
18. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458 [TBL] [Abstract][Full Text] [Related]
19. Point mutations in the Ki-ras2 gene of codon 12 in the Dunning R-3327 Prostatic Adenocarcinoma system. Blount LV; Cooke DB Prostate; 1996 Jan; 28(1):44-50. PubMed ID: 8545280 [TBL] [Abstract][Full Text] [Related]
20. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]